Qing Bei Zeng
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Qing Bei Zeng has been serving as Chief Scientist, Senior VP & Deputy GM at Dizal (Jiangsu) Pharmaceutical Co., Ltd. since 2017.
Dr. Zeng holds a doctorate degree from The Ohio State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/12/2025 | 252.000 ( 0,09 % ) | 1 M $ | 30/06/2026 | |
| 16/12/2025 | 110.000 ( 0,02 % ) | 647 316 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Director Técnico/Científico/I+D | 01/12/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Dizal (Jiangsu) Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.